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Prevalence of Congenital Heart Defects Associated with Down 
Syndrome in Korea
Congenital heart defect (CHD) is common in infants with Down syndrome (DS), which is 
the principle cause of mortality. However, there is no data available for the frequency and 
types of CHD in infants with DS in Korea. We investigated the frequency of CHD in infants 
with DS in Korea. After the survey on birth defects was conducted throughout the country, 
the prevalence of CHD in DS in 2005-2006 was calculated. This study was conducted based 
on the medical insurance claims database of the National Health Insurance Corporation. 
The number of total births in Korea was 888,263 in 2005-2006; of them, 25,975 cases of 
birth defects were identified. The prevalence of DS was 4.4 per 10,000 total births, 
accounting for 1.5% of all birth defects. Of the 394 infants with DS, 224 (56.9%) had a 
CHD. Atrial septal defect was the most common defect accounting for 30.5% of DS 
followed by ventricular septal defect (19.3%), patent duct arteriosus (17.5%), and 
atrioventricular septal defect (9.4%). Our study will be helpful to demonstrate the current 
status of DS and to identify the distribution of CHD in infants with DS in Korea. 
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INTRODUCTION
Down syndrome (DS) is a well-known genetic disorder that 
places affected individuals at increased risk for several medical 
morbidities, especially congenital heart defect (CHD). The prev-
alence of CHD among infants born with DS is reported to range 
from 40% to 60% compared with 0.8% in the general population 
(1). The prevalence of DS, the most frequent chromosomal ab-
normality, has remained stable over time with increasing aver-
age maternal age despite higher prenatal detection rates. How-
ever, there are few reports concerning the prevalence of CHD in 
infants with DS in Korea.
 The frequency of CHD in infants with DS varies among geo-
graphical locations. In the United States of America and Europe, 
an atrioventricular septal defect (AVSD) is reportedly the most 
common CHD associated with DS (2-8). However, in Asian com-
munities, a ventricular septal defect (VSD) is the most common 
defect (9, 10), whereas in Latin America, an atrial septal defect 
(ASD) is reportedly the most common defect (11). For Korea, 
however, there are no data available for the frequency and types 
of CHD in infants with DS in Korea.
 The aim of this study was to identify the frequency and distri-
bution of CHD in infants with DS in Korea and compare it with 
the prevalence in infants with CHD who have non-chromosom-
al abnormalities. To our knowledge, this study was planned to 
establish epidemiologic data about the distribution of CHD in 
infants with DS. We believe this study will provide baseline data 
for future studies on the epidemiology and management of in-
fants with DS in Korea. 
MATERIALS AND METHODS
This study analyzed data from the Congenital Anomaly Survey 
and the Infant and Maternal Mortality Survey, which were both 
performed by the Korea Institute for Health and Social Affairs 
(12, 13). These surveys were conducted using data from all Ko-
rean medical institutes from January 1, 2005 to December 31, 
2006, and based on the medical insurance claims database of 
the National Health Insurance Corporation. 
 Research categories and subjects were selected in advance 
through pilot surveys, and a web-based research system was 
regulated to improve data acquisition and screening. During 
the data collection period, progress was monitored in real time, 
and corrective actions were implemented to respond to issues 
raised by the participating institutes. The data collected through 
these processes were reviewed and re-checked for accuracy, 
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and differences or overlaps in birth defect diagnoses among the 
medical institutes were adjusted for uniform reporting. 
 Since the possible period of diagnosis for birth defects is wide, 
we only included data from the first postnatal year. This approach 
is in agreement with other international bodies, such as Inter-
national Clearinghouse for Birth Defects Surveillance and Re-
search (ICBDSR) and European Surveillance of Congenital Ano-
malies (EUROCAT), which generally include only data from the 
first postnatal year in their analysis. The Korean Medical Record 
Association integrated the database of birth defects with ongo-
ing surveillance at each medical institute. 
 Birth defects were classified by Q code, according to the 10th 
revision of the International Classification of Diseases. Defects 
were analyzed according to the methods of EUROCAT, ICBDSR, 
and the National Birth Defects Prevention Network (NBDPN), 
which are global leaders in this field. In this study, only study 
subjects who were confirmed by chromosomal analysis were 
included and cases with rule-out diagnoses of birth defects and 
mismatching between disease diagnoses and medical records 
were excluded. Regarding fetal cardiac anomalies, which are 
closely accompanied by other heart defects, we focused only 
on the major anomalies, and divided the results into 3 groups 
with the assistance of the fetal heart specialist. 
 In this study, we calculated the total birth prevalence rate of 
each anomaly per 10,000 births, with the number of total births 
as the denominator, and the number of each anomaly as the 
numerator. We collected data regarding birth defects, in the first 
postnatal year, from the medical insurance claims database 
(sorted by main disease code and sub-code), and attempted to 
collect all information prior to analysis. Among the research 
categories, only easily accessible data regarding the risk factors 
of birth defects were utilized. Collected variables were maternal 
age, paternal age, parental occupation, parental education lev-
el, gestational age, birth weight, and pregnancy with or without 
multiple gestations.
Statistical analysis
We reviewed maternal and paternal age, parental job, education-
al background, gestational age at delivery, birthweight, and fetal 
sex as variables for analysis and performed the Poisson distri-
bution to calculate 95% confidence intervals of DS prevalence. 
Ethics statement
The study protocol was approved by the institutional review 
board of Gangnam Severance Hospital (IRB No. 3-2011-0286). 
Informed consent was waived by the board.
RESULTS
The number of total births in Korea was 888,263 in 2005-2006; 
of them, 25,975 had birth defects with a prevalence of 292.4 per 
10,000 total births. The prevalence of chromosomal anomalies 
was 7.9 per 10,000 total births, accounting for 2.7% of all birth 
defects in 2005-2006. DS was the most common chromosomal 
anomaly and its prevalence was 4.4 per 10,000 total births, ac-
counting for 1.5% of all birth defects (Table 1). 
 Baseline demographic characteristics of infants with DS, chro-
mosomal abnormalities, and non-chromosomal abnormalities 
are presented in Table 2. There were significant differences in 
maternal age, paternal age, gestational age at delivery, and birth 
weights among infants with DS and those with non-chromoso-
mal abnormalities. 
 Of the 394 infants with DS, 224 (56.9%) had a CHD (Table 3). 
There were significant differences in gestational age at delivery 
and birth weights between DS without CHD and those with CHD.
 The data for CHD in infants with DS are summarized in Table 
4. Atrial septal defect (ASD) was the most common defect re-
ported as 30.5%, ventricular septal defect (VSD) 19.3%, patent 
ductus arteriosus (PDA) 17.5%, atrioventricular septal defect 
(AVSD) (9.4%), and tetralogy of Fallot (TOF) 2.5%. There were 
Table 1. Prevalence of major chromosomal anomalies in Korea, 2005-2006
Birth defects 
No. (%) in birth defects 
(n = 25,975)
Prevalence per 10,000 
total births (95% CI)
Trisomy 13 9 (0.03) 0.1 (0.04-0.17)
Trisomy 18 42 (0.16) 0.47 (0.33-0.62)
Down’s syndrome 394 (1.52) 4.44 (4.0-4.87)
Turner’s syndrome 32 (0.12) 0.36 (0.24-0.49)
Kleinfelter’s syndrome 13 (0.05) 0.15 (0.07-0.23)
Wolff-Hirschorn syndrome 4 (0.02) 0.05 (0-0.09)
Cri-du-chat syndrome 12 (0.05) 0.14 (0.06-0.21)
Other chromosomal anomalies 194 (0.75) 2.18 (1.88-2.49)
Total 700 (2.69) 7.88 (7.3-8.46)
CI, confidence interval.
Table 2. Demographic characteristics of Down syndrome, chromosomal abnormalities, and non-chromosomal abnormalities in Korea
Parameters
DS 
(n = 394)
Chromosomal abnormalities 
(n = 700)
Non- chromosomal abnormalities 
(n = 25,275)
P* P †
Maternal age (yr) 33.0 ± 5.4 32.2 ± 5.2 30.5 ± 4.0 < 0.001 < 0.001
Paternal age (yr) 35.6 ± 5.5 34.7 ± 5.1 33.2 ± 4.3 < 0.001 < 0.001
Gestational age (weeks) 35.1 ± 6.0 34.7 ± 6.2 37.9 ± 3.5 < 0.001 < 0.001
Birth weight (grams) 2,585 ± 925 2,417 ± 1,002 3,040 ± 683 < 0.001 < 0.001
Fetal sex ratio (M/F) 1.3 1.1 1.3 0.812 0.118
*Comparison between groups with DS and non-chromosomal abnormalities; †Comparison between groups with chromosomal abnormalities and non-chromosomal abnormali-
ties. M, male; F, female; DS, Down syndrome.
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Table 3. Demographic characteristics of Down syndrome without congenital heart 
defect and those with congenital heart defect
Parameters
Total patients with Down syndrome
Pwithout CHD 
(n = 170)
with CHD 
(n = 224)
Maternal age (yr) 32.9 ± 5.8 33.0 ± 5.2 0.912
Paternal age (yr) 35.9 ± 4.9 35.4 ± 5.7 0.511
Gestational age (weeks) 31.6 ± 7.5 37.7 ± 2.1 < 0.001
Birthweight (grams) 2,128 ± 1,167 2,897 ± 525 < 0.001
Fetal sex ratio (M/F) 1.6 1.1 0.116
M, male; F, female; CHD, congenital heart defect.
Table 4. Distribution of major congenital heart defects in Down syndrome
Heart defects
No. (%) in DS 
(n = 394)
No. (%) in chromosomal  
abnormalities (n = 700)
No. (%) in Non-chromosomal  
abnormalities (n = 25,275)
P* P †
ASD (Q21.1) 120 (30.5) 163 (23.3) 5719 (22.6) < 0.001 0.681
VSD (Q21.0) 76 (19.3) 109 (15.6) 3304 (13.1) < 0.001 0.054
PDA (Q 25.0) 69 (17.5) 81(11.6) 1194 (4.7) < 0.001 < 0.001
PV atresia/stenosis (Q22.0/Q22.1) 4 (1.0) 6 (0.9) 426 (1.7) 0.304 0.091
TOF (Q21.3) 10 (2.5) 20 (2.9) 361 (1.4) 0.067 0.002
AVSD (Q 21.2) 37 (9.4) 43 (6.1) 271 (1.1) < 0.001 < 0.001
CoA (Q25.1) 8 (2.0) 18 (2.6) 204 (0.8) 0.008 < 0.001
DORV (Q20.1) 2 (0.5) 9 (1.3) 168 (0.7) 0.703 0.049
TGA (Q20.3) 1 (0.3) 2 (0.3) 143 (0.6) 0.411 0.327
Single ventricle (Q20.4) 1 (0.3) 2 (0.3) 29 (0.1) 0.423 0.196
*Comparison between groups with DS and non-chromosomal abnormalities; †Comparison between groups with chromosomal abnormalities and non-chromosomal abnormali-
ties. DS, Down syndrome; ASD, atrial septal defect; VSD, ventricular septal defect; PDA, patent ductus arteriosus; PV, pulmonary valve; TOF, tetralogy of Fallot; AVSD, atrioven-
tricular septal defect; CoA, coarctation of aorta; DORV, double outlet right ventricle; TGA, transposition of great arteries. 
Table 5.  Frequency of congenital heart defects in patients with Down syndrome, chromosomal abnormalities, and non-chromosomal abnormalities in Korea
Heart defects
No. (%) in DS  
(n = 394)
No. (%) in chromosomal  
abnormalities (n = 700)
No. (%) in Non-chromosomal  
abnormalities (n = 25,275)
P* P †
Single heart defects
ASD (Q21.1)
VSD (Q21.0)
PDA (Q 25.0)
PV atresia/stenosis (Q22.0/Q22.1)
TOF (Q21.3)
AVSD (Q 21.2)
CoA (Q25.1)
DORV (Q20.1)
TGA (Q20.3)
Single ventricle (Q20.4)
122 (31.0)
36 (9.1)
16 (4.1)
19 (4.8)
0 (0)
10 (2.5)
29 (7.4)
2 (0.5)
2 (0.5)
1 (0.3)
1 (0.3)
190 (27.1)
49 (7.0)
25 (3.6)
26 (3.7)
2 (0.3)
18 (2.6)
32 (4.6)
6 (0.9)
9 (1.3)
1 (0.1)
2 (0.3)
7,997 (31.6)
3,295 (13.0)
1,772 (7.0)
517 (2.0)
229 (0.9)
352 (1.4)
233 (0.9)
75 (0.3)
165 (0.7)
141 (0.6)
29 (0.1)
0.775
0.022
0.022
< 0.001
0.058
0.056
< 0.001
0.448
0.722
0.419
0.423
0.012
< 0.001
< 0.001
0.002
0.085
0.009
< 0.001
0.009
0.043
0.142
0.196
Multiple heart defects
VSD+ASD
ASD+PDA
VSD+ASD+PDA
VSD+PDA
VSD+ASD+CoA
102 (25.9)
28 (7.1)
31 (7.9)
19 (4.8)
7 (1.8)
3 (0.8)
140 (20.0)
38 (5.4)
40 (5.7)
25 (3.6)
9 (1.3)
6 (0.9)
2,704 (10.7)
1,085 (4.3)
684 (2.7)
184 (0.7)
121 (0.5)
55 (0.2)
< 0.001
0.007
< 0.001
< 0.001
< 0.001
0.06
< 0.001
0.145
< 0.001
< 0.001
0.003
0.006
Total 224 (56.9) 330 (47.1) 10,701 (42.3) < 0.001 0.011
*Comparison between groups with DS and non-chromosomal abnormalities; †Comparison between groups with chromosomal abnormalities and non-chromosomal abnormali-
ties. DS, Down syndrome; ASD, atrial septal defect; VSD, ventricular septal defect; PDA, patent ductus arteriosus; PV, pulmonary valve; TOF, tetralogy of Fallot; AVSD, atrioven-
tricular septal defect; CoA, coarctation of aorta; DORV, double outlet right ventricle; TGA, transposition of great arteries.
significant differences in ASD, VSD, PDA, AVSD, and coarcta-
tion of the aorta (CoA) between infants with DS and those with 
non-chromosomal abnormalities and in PDA, TOF, AVSD, and 
CoA between infants with chromosomal abnormalities and those 
with non-chromosomal abnormalities. 
 Of the 394 infants with DS, 122 (31.0%) had single heart de-
fects and 102 (25.9%) had multiple heart defects. There was no 
significant difference in single heart defects between infants 
with DS and those with non-chromosomal abnormalities, wher-
eas there was a significant difference in multiple heart defects 
between infants with DS and those with non-chromosomal ab-
normalities. CHD was significantly more frequent in infants 
with DS than in infants with non-chromosomal abnormalities 
(Table 5).
 With regard to CHD, the frequencies of total CHD, single heart 
defects, and multiple heart defects were higher in infants with 
DS than in infants with other chromosomal abnormalities. How-
ever, extracardiac anomalies were seen more frequently in in-
fants with Trisomy 13 or Turner syndrome than in those with 
DS (Table 6).
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 Table 7 shows the relative risk of all infants with chromosom-
al abnormalities and CHD according to maternal age, paternal 
age, infant sex, and gestational age at delivery. The proportion 
of infants with DS who had a CHD did not differ by paternal age, 
infant sex, or gestational age. However, infants with DS born to 
mothers who were ≥ 35 yr of age were more likely to have a CHD 
than infants with DS born to mothers who were < 35 yr of age 
(relative risk, 1.467; 95% confidence interval [CI], 0.6-1.7). 
DISCUSSION
This is the first nationwide study of CHDs in infants with DS in 
Korea. The total number of births in Korea was 888,263 in 2005-
2006, with 25,975 birth defects in 25,335 live births and 640 still-
births. The prevalence of DS was 4.4 per 10,000 total births, ac-
counting for 1.5% for all birth defects. We found that CHDs oc-
curred in 56.3% of infants with DS, which is similar with the prev-
alence presented in the previous literature (44%-58%). In our 
study, ASD was the most common CHD, occurring in 30.5% of 
all DS, followed by VSD (19.3%), PDA (17.5%), and AVSD (9.4%). 
 DS is the most common chromosomal abnormality in infants 
who survived birth, and its association with CHD is well estab-
lished. Despite the increasing prenatal detection rate and ter-
mination of pregnancies due to DS diagnosis, there has been 
no change in the prevalence of DS for the last decade (14-17). 
The prevalence of DS in our study was considerably lower than 
in previous studies conducted in Korea. The prevalence of DS 
was 14 and 26.7 per 10,000 total births in Shin et al. (18) and Jun 
et al. (19), respectively. However, since two previous studies were 
limited to only a few institutions and not nationwide, it may not 
reflect the overall prevalence of DS in Korea. Also, prenatal di-
agnostic tests may have increased the rate of terminations of 
pregnancy after prenatal diagnosis of DS in Korea. That may have 
contributed low frequency of the present study.
 AVSD, VSD, and ASD were the most common types of CHD, 
and previous studies have reported that the distribution of CHDs 
in infants with DS may vary according to ethnicity. Most studies 
regarding the distribution of CHD in DS were conducted in Cau-
casian populations, where AVSD was reported to be the most 
common CHD. The few Asian studies have reported varied re-
sults. For example, VSD has been reported in the range of 43.6%-
52.9% of all CHDs in the Asian population, while AVSD has been 
reported in the range of 11.8%-22.0% (20-22). In contrast, Cau-
casian studies have reported that AVSD occurs in 35.7%-60.1% 
of DS cases, while VSD occurs in 15.6-35.0% of cases (23, 24). 
 Our results were unique compared to those from prior Asian 
studies. ASD (30.5%) was the most common CHD in infants with 
DS, followed in frequency by VSD, PDA, and AVSD. We also found 
that AVSD accounted for only 9.4% of all CHDs, which is in stark 
contrast to the prevalence of AVSD in Caucasian studies. 
 Similar to findings in Mexican cases of DS, we found that ASD 
was the most common CHD, while AVSD was the least common, 
as reported in previous Asian studies. AVSD occurred in only 
9% of all CHDs in Mexican infants with DS, whereas ASD, VSD, 
and PDA were more common. Furthermore, the total number 
of VSD cases (19.3%) in our results was much lower than in pre-
vious Asian studies (6, 20, 25). 
 In our study, the AVSD was the fourth most prevalent CHD, 
accounting for 9.4% of CHDs in infants with DS. However, as a 
single heart defect, AVSD was the second most prevalent defect, 
occurring in 7.4% of all single heart defects, second only to ASD. 
Table 6. Chromosome anomalies detected in infants with single heart defect, multiple heart defect, and extracardiac anomalies
Birth defects 
No. (%) in birth defects 
(n = 25,975)
Congenital heart defects 
(n = 11,031)
Single heart defects 
(n = 8,187)
Multiple heart defects 
(n = 2,844)
Extracardiac anomalies 
(n = 15,986)
Trisomy 13 9 (0.03) 3 (33.3) 2 (22.2) 1 (11.1) 5 (55.6)
Trisomy 18 42 (0.17) 11 (26.2) 7 (16.7) 4 (9.5) 10 (23.8)
Down’s syndrome 394 (1.52) 224 (56.8) 122 (31.0) 102 (25.9) 64 (16.2)
Turner’s syndrome 32 (0.12) 6 (18.8) 4 (12.5) 3 (9.4) 13 (40.6)
Kleinfelter’s syndrome 13 (0.05) 3 (23.1) 2 (15.4) 1 (7.7) 5 (38.5)
Wolff-Hirschorn syndrome 4 (0.02) 1 (25.0) 1 (25.0) 0 (0) 3 (75)
Cri-du-chat syndrome 12 (0.05) 5 (41.7) 3 (25.0) 2 (16.7) 4 (33.3)
Other chromosomal anomalies 194 (0.74) 77 (39.7 ) 49 (25.3) 28 (14.4) 90 (46.4)
Total 700 (2.7) 330 (47.1) 190 (27.1) 140 (20.0) 195 (27.9)
Data are presented as No. (%) in each chromosomal anomaly unless otherwise specified.
Table 7. Adjusted risk factors of infants with CHD and chromosomal abnormalities
Risk factors
All chromosom-
al abnormalities
Infants with chromo-
somal abnormalities 
and CHD
RR (95% CI)
Maternal age
 < 35
 ≥ 35
453
195
219 (48.3)
85 (43.6)
1 (referent)
1.467 (0.611-1.724)
Paternal age
 < 35
 ≥ 35
243
213
144 (59.3)
121 (56.8)
1 (referent)
0.931 (0.589-1.474)
Infant sex
  Male
  Female
354
313
175 (49.4)
154 (49.2)
1 (referent)
0.996 (0.674-1.467)
Gestational weeks
 ≥ 37
 < 37
406
254
236 (58.1)
70 (27.6)
1 (referent)
0.987 (0.612-1.467)
CHD, congenital heart defect; RR, relative risk; CI, confidence interval.
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Regarding the prevalence of CHD in infants with DS born to wo-
men < 35 yr and those ≥ 35 yr, we found that mothers ≥ 35 yr 
were more likely to give birth to a DS child with a CHD. 
 It has been reported that the prevalence of CHD varies, de-
pending on the presence of DS and other non-chromosomal 
abnormalities. For instance, the Baltimore-Washington Infant 
Study found AVSD in only 2.8% of non-DS cases, compared to 
60.1% of DS cases. As indicated by various studies, several CHDs 
observed in non-chromosomal abnormalities are rare, although 
they are common in DS cases.
 Advanced maternal age is a well-known risk factor for DS. In 
Korea, there is an ongoing trend towards delayed childbearing, 
and older mothers are known to have an increased risk of preg-
nancies with chromosomal anomalies, including DS. An increase 
in the prevalence of DS will result in a significant increase in the 
cost of early diagnosis and effective management of CHD, as 
the current trend is to treat these infants in the same manner as 
non-syndromic individuals. In our study, maternal age, paternal 
age, and fetal sex ratio were not significantly different between 
DS infants with or without CHD. 
 Differences in the prevalence of ASD, VSD, PDA, AVSD, and 
CoA among patients with DS or non-chromosomal abnormali-
ties were found to statistically significant. However, differences 
in the prevalence of PDA, TOF, AVSD, CoA, and DORV among 
patients with DS or non-chromosomal abnormalities were not 
statistically significant. Unfortunately, we cannot accurately 
perform more detailed statistical analysis, as the majority of the 
data had insufficient detail regarding medication taken during 
pregnancy, or maternal employment and living environment, 
which are all important environmental factors that could affect 
the prevalence of DS. Therefore, future research is needed for 
more accurate and objective analysis.
 The reported frequencies of CHD may vary with the variabil-
ity of classification criteria, the conduct of postmortem exami-
nation, examiner experience, social and economic factors and 
so on. With advanced ultrasound technology and increasing 
experience and interest in prenatal screening, it may increase 
the detection rate of CHD. However, since postmortem exami-
nations of stillborn infants are conducted less commonly in Ko-
rea than in other countries, this may result in the underestima-
tion of the frequency of CHD.
 Our results indicate a need for timely identification and in-
creased awareness of the development of CHD in DS, which 
might help decrease neonatal morbidity and increase overall 
health and wellness. It is necessary to assess and collect period-
ic data, so that trends can be monitored for early recognition 
and optimal management of CHD in infants with DS. Our study 
contributes to the understanding of the effects of DS, and pro-
vides the basis for identifying the distribution of CHD in infants 
with DS in Korea. 
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